Pharmazz Inc. announces that Dr. Neil Marwah has joined the Company as its President
11 sept. 2024 07h00 HE
|
Pharmazz, Inc.
Pharmazz Inc. announces that Dr. Neil Marwah has joined the Company as its President.
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
22 mars 2024 07h00 HE
|
Pharmazz, Inc.
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin®) as a resuscitative agent
Pharmazz Inc. Announces Key Publications Regarding the Role of Adrenergic Receptors in Venous Blood Return to Treat Shock
20 mars 2023 07h30 HE
|
Pharmazz, Inc.
Centhaquine (Lyfaquin®) is an adrenergic agent that increases cardiac preload by activating alpha2B adrenergic receptors to increase venous blood return to the heart and decreases cardiac afterload by...